Synageva BioPharma GEVA today announced the pricing of its previously announced
underwritten public offering of common stock consisting of 2,150,000
shares at $47.53 per share. In connection with this offering, Synageva
granted to the underwriters a 30-day option to purchase 322,500
additional shares of common stock.
Morgan Stanley and J.P. Morgan are acting as joint book-running managers
in the offering, and Cowen and Company, Canaccord Genuity Inc., and
Leerink Swann LLC are acting as co-managers in the offering.
The securities described above are being offered by Synageva pursuant to
a Form S-3 shelf registration
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in